Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.26.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities

The following Common Stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

 

   

September 30, 2026

(Unaudited)

   

September 30, 2025

(Unaudited)

 
Series L Preferred Stock 1     36,347  1     305,992  2 
Series M Preferred Stock 3     1,175,657       —  
Greenshoe Rights - Series L Preferred Stock    

1,165,934

 1    

1,420,098

 2
Greenshoe Rights - Series M Preferred Stock 3    

5,684,527

      —  
Options to purchase Common Stock     23,902       23,902  
Warrants to purchase Common Stock     9,393,734       1,978,375  
Total anti-dilutive securities     17,480,101       3,728,367  

 

1 As of September 30, 2026, the shares of Series L Preferred Stock are convertible into shares of Common Stock at the holder’s option using a conversion price of $11.35 per share.
   
2

As of September 30, 2025, the shares of Series L Preferred Stock are convertible into shares of Common Stock at the holder’s option using a conversion price of $16.05 per share.

   
3 As of September 30, 2026, the shares of Series M Preferred Stock are convertible into shares of Common Stock at the holder’s option using a conversion price of $6.10 per share.